Genomics and Bioinformatics Marseille Core Facility
Aix-Marseille Université
GBiM addresses the reasearch field of heath by providing a large array of genomics and bioinformatics services and tools.
LS7_2 - Medical technologies and tools (including genetic tools and biomarkers) for prevention, diagnosis, monitoring and treatment of diseases - Prevention, Diagnosis and Treatment of Human Diseases
Genomics
Transcriptomics
Bioinformatics
mutation
disease
GBiM is open to scientific communities of both the academic and private sectors, upon request to the facility scientific head manager.
Project for access has to be approved by a local committee for approval.
The services provided by GBiM include next generation sequencing (NGS), Sanger sequencing, qRT-PCR, CGH array and bioinformatics services.
Transcriptome by DNA microarray is available, but will progressively be replaced by RNA-Seq.
For NGS sequencing into details, the proposed services are the following:
- genomics : whole exome, targeted exome, amplicon sequencing, any DNA-Seq technology which might be developed,
- transcriptomics : RNA-Seq (whole transcriptome or targeted transcriptome),
- epigenomics : ChIP-Seq, High-Throughput bisulfite sequencing,
- bioinformatics services to contribute to both the experimental design and analysis and interpretation of the generated data.
The analysis can include primary data analysis, but also, if needed, further analysis, such as variant search, CNV search or linkage analysis, depending on the researcher’s needs.
The bioinformatician staff of the facility can be consulted for assistance and to provide their expertise to the users.